Follow
Chetanya Pandya
Chetanya Pandya
Global Head of Data Engineering, Oncology
Verified email at sanofi.com
Title
Cited by
Cited by
Year
Enzyme promiscuity: engine of evolutionary innovation
C Pandya, JD Farelli, D Dunaway-Mariano, KN Allen
Journal of Biological Chemistry 289 (44), 30229-30236, 2014
1582014
Panoramic view of a superfamily of phosphatases through substrate profiling
H Huang, C Pandya, C Liu, NF Al-Obaidi, M Wang, L Zheng, ...
Proceedings of the National Academy of Sciences 112 (16), E1974-E1983, 2015
1462015
Development and clinical application of an integrative genomic approach to personalized cancer therapy
AV Uzilov, W Ding, MY Fink, Y Antipin, AS Brohl, C Davis, CY Lau, ...
Genome medicine 8, 1-20, 2016
1002016
Genomic profiling reveals mutational landscape in parathyroid carcinomas
C Pandya, AV Uzilov, J Bellizzi, CY Lau, AS Moe, M Strahl, W Hamou, ...
JCI insight 2 (6), 2017
992017
Divergence of Structure and Function in the Haloacid Dehalogenase Enzyme Superfamily: Bacteroides thetaiotaomicron BT2127 Is an Inorganic Pyrophosphatase
H Huang, Y Patskovsky, R Toro, JD Farelli, C Pandya, SC Almo, KN Allen, ...
Biochemistry 50 (41), 8937-8949, 2011
452011
Consequences of domain insertion on sequence-structure divergence in a superfold
C Pandya, S Brown, U Pieper, A Sali, D Dunaway-Mariano, PC Babbitt, ...
Proceedings of the National Academy of Sciences 110 (36), E3381-E3387, 2013
332013
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma
E Bangi, P Smibert, AV Uzilov, AG Teague, S Gopinath, Y Antipin, R Chen, ...
Iscience 24 (3), 2021
182021
RAPiD—an agile and dependable RNA-Seq framework
H Shah, Y CW, R Castellanos, C Pandya, Z Giles
The 65th Annual Meeting of The American Society of Human Genetics, 2015
152015
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma
AV Uzilov, KC Cheesman, MY Fink, LC Newman, C Pandya, Y Lalazar, ...
Molecular Case Studies 3 (3), a001602, 2017
132017
Molecular and phenotypic profiling of drug product and post-infusion samples from CRB-402, an ongoing: phase I clinical study of bb21217 a BCMA-directed CAR T cell therapy
OC Finney, A Yeri, P Mao, C Pandya, E Alonzo, G Hopkins, S Hymson, ...
Blood 136, 3-4, 2020
112020
Parafibromin abnormalities in ossifying fibroma
J Costa-Guda, C Pandya, M Strahl, P Taik, R Sebra, R Chen, AV Uzilov, ...
Journal of the Endocrine Society 5 (7), bvab087, 2021
82021
Structure‐guided approach for detecting large domain inserts in protein sequences as illustrated using the haloacid dehalogenase superfamily
C Pandya, D Dunaway‐Mariano, Y Xia, KN Allen
Proteins: Structure, Function, and Bioinformatics 82 (9), 1896-1906, 2014
52014
Markers of initial and long-term responses to idecabtagene vicleucel (Ide-Cel; bb2121) in the CRB-401 Study in Relapsed/Refractory Multiple Myeloma
EG Thompson, Y Jiang, TB Campbell, J Fuller, S Kaiser, ...
Blood 134, 4328, 2019
32019
Correlative Analysis from CRB-402: An Ongoing Phase 1 Clinical Study of bb21217 Anti-BCMA CAR T Cell Therapy
OC Finney, A Yeri, C Pandya, E Alonzo, K Endelberg, G Hopkins, A Ladd, ...
MOLECULAR THERAPY 28 (4), 575-575, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–14